Development of Criteria for Probiotic Bacteria Selection for Broadening the Spectrum of Available Anti-Cholera Drugs
https://doi.org/10.21055/0370-1069-2012-4-69-72
Abstract
V. cholerae – high or moderate, adhesion – only moderate, acid forming activity – high or moderate. The preventive and medical efficiency of 5 selected strains of lactobacilli and 1 strain of bifidobacterium is demonstrated on the experimental model of cholera. Underlined is the prospective use of probiotics as additional preparations of choice against cholera infection.
References
1. Andrusenko I.T., Podosinnikova L.S., Bardykh I.D. [Search for new methods of cholera treatment]. Epidemiol. Infek. Bol. 2007; 5:49–52.
2. Bardykh I.D., Kruglikov V.D., Mazrukho B.L., Ryzhko I.V., Moskvitina E.A., Tsuraeva R.I. et al. [Experimental evaluation of efficacy of Lactobacilli in prophylaxis and treatment of cholera]. Zh. Mikrobiol. Epidemiol. Immunobiol. 2001; 2:68–71.
3. Gaevskaya N.E., Kudryakova T.A., Makedonova L.D., Kachkina G.V., Alieva A.A., Sayamov S.R. [Selection of bateriophages for treatment of experi- mental cholera, caused by classical cholera vibrions]. Sovrem. Naukoemkie Tekhnol. 2004; 3:11–5.
4. Dudina N.A. [Multidrug resistance of strains of Vibrio cholerae El Tor, isolated from people in Russia in 2005]. Klin. Mikrobiol. Antimikrob. Khimioter. 2006; 8(2):16–7.
5. Kravtsov E.G., Ermolaev A.V., Anokhina I.V., Yashina N.V., Chesnokova V.L., Dolin M.V. [Adhesion characteristics of lactobacillus is a criterion of the probiotic choice]. Byul. Eks. Biol. Med. 2008; 145(2):192–5.
6. Kruglikov V.D., Ryzhko I.V., Tsuraeva R.I., Drobotkovskaya N.V., Pushkareva N.D., Bardykh I.D. [Examination of influence of acquired resis- tance to rifampicine on stability of biological properties of Lactobacillus aci- dophilus BKM B–2020 D strain]. Biotekhnologia. 1996; 7:32–5.
7. Mayevskaya M.V. [Application of probiotics in gastroenterology]. Ros. Zh. Gastroenterol. Gepatol. Koloproktol. 2009; 19(6):65–72.
8. [Control methods. Biological and microbiological factors. Pre- registration system for pre-clinical drug safety studies. Selection, control and storage of industrial strains, used in probiotics production. MR 4.2.2602-10. 4.2]. M.; 2010.
9. Sheveleva M.A., Ramenskaya G.V. [Modern concept of the use of various groups of probiotics in antibiotic therapy]. Antibiotik. Chimioter. 2009; 54(3–4):61–8.
10. Yankovsky D.S., Dyment G.S. [Bifidobacteria and lactobacilli as the optimal basis for modern probiotics]. Sovr. Pediatriya. 2006; 10(3):1–10.
11. Boirivant M, Strober W. The mechanism of action of probiotics. Curr. Opin. Gastroenterol. 2007; 23(6):679–92.
Review
For citations:
Kruglikov V.D. Development of Criteria for Probiotic Bacteria Selection for Broadening the Spectrum of Available Anti-Cholera Drugs. Problems of Particularly Dangerous Infections. 2012;(4(114)):69-72. (In Russ.) https://doi.org/10.21055/0370-1069-2012-4-69-72